Total Funding
26
54
Total FundingNon-equity Assistance raised
Growth Score
-1 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
160451
AlgometRx enables a fundamental paradigm shift in pain assessment and analgesic prescribing.
- Julia Finkel: Founder, Chief Scientific Advisor, and Board Member
About the Company
AlgometRx Nociometer enables a fundamental paradigm shift in pain assessment and analgesic prescribing. Their novel technology and algorithms analyze pupil dilation in response to neuroselective stimulation to formulate a nociceptive profile. This new construct is used to characterize pain type, intensity and assess the pharmacodynamic impact of
analgesics. This transformative platform technology can be applied to any population.
